Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 12 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Fostira, Florentia  [Clear All Filters]
Journal Article
Stevens, K. N., Vachon C. M., Lee A. M., Slager S., Lesnick T., Olswold C., et al. (2011).  Common breast cancer susceptibility loci are associated with triple-negative breast cancer.. Cancer Res. 71(19), 6240-9.
Haiman, C. A., Chen G. K., Vachon C. M., Canzian F., Dunning A., Millikan R. C., et al. (2011).  A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer.. Nat Genet. 43(12), 1210-4.
Tsakiri, K., Kotoula V., Lakis S., üller J., Fostira F., Bobos M., et al. (2017).  Crizotinib Failure in a TPM4-ALK –Rearranged Inflammatory Myofibroblastic Tumor With an Emerging ALK Kinase Domain Mutation. JCO Precision Oncology. 1 - 7.
Fountzilas, E., Kotoula V., Zagouri F., Giannoulatou E., Kouvatseas G., Pentheroudakis G., et al. (2016).  Disease evolution and heterogeneity in bilateral breast cancer.. Am J Cancer Res. 6(11), 2611-2630.
Kotoula, V., Fostira F., Papadopoulou K., Apostolou P., Tsolaki E., Lazaridis G., et al. (2017).  The fate of BRCA1-related germline mutations in triple-negative breast tumors.. Am J Cancer Res. 7(1), 98-114.
Purrington, K. S., Slager S., Eccles D., Yannoukakos D., Fasching P. A., Miron P., et al. (2014).  Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.. Carcinogenesis. 35(5), 1012-9.
Fostira, F., Thodi G., Sandaltzopoulos R., Fountzilas G., & Yannoukakos D. (2010).  Mutational spectrum of APC and genotype-phenotype correlations in Greek FAP patients.. BMC Cancer. 10, 389.
Kotoula, V., Lakis S., Tikas I., Giannoulatou E., Lazaridis G., Papadopoulou K., et al. (2019).  Pathogenic BRCA1 mutations may be necessary but not sufficient for tissue genomic heterogeneity: Deep sequencing data from ovarian cancer patients.. Gynecol Oncol. 152(2), 375-386.
Fostira, F., Tsitlaidou M., Papadimitriou C., Pertesi M., Timotheadou E., Stavropoulou A. V., et al. (2012).  Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.. Breast Cancer Res Treat. 134(1), 353-62.
Stavropoulou, A. V., Fostira F., Pertesi M., Tsitlaidou M., Voutsinas G. E., Triantafyllidou O., et al. (2013).  Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases.. PLoS One. 8(3), e58182.
Kotoula, V., Fostira F., & Fountzilas E. (2019).  Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer-Beyond the Misdiagnosis.. JAMA Oncol. 5(5), 740-741.
Thodi, G., Fostira F., Sandaltzopoulos R., Nasioulas G., Grivas A., Boukovinas I., et al. (2010).  Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families.. BMC Cancer. 10, 544.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές